Public limited company · Leuven · incorporated on 06/08/2015
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | 12,7 k € | -87.5% | 101,4 k € | -74.5% | 397,0 k € | +98.7% | 199,8 k € | +64.5% | 121,5 k € | +46.4% | 83,0 k € | ||||||
| EBITDA | -60,5 k € | +91.6% | -721,2 k € | +55.5% | -1,6 M € | -1.0% | -1,6 M € | -6.7% | -1,5 M € | +0.7% | -1,5 M € | -0.4% | -1,5 M € | -135.8% | -640,4 k € | -11.4% | -574,9 k € | -10.8% | -519,0 k € | +13.0% | -596,2 k € | |
| Operating profit | -64,7 k € | +94.3% | -1,1 M € | +54.9% | -2,5 M € | +4.7% | -2,6 M € | +0.2% | -2,6 M € | +1.2% | -2,7 M € | +2.5% | -2,7 M € | -23.0% | -2,2 M € | -10.9% | -2,0 M € | -50.8% | -1,3 M € | -121.5% | -598,2 k € | |
| Profit/loss | -238,9 k € | +83.7% | -1,5 M € | +45.4% | -2,7 M € | -3.3% | -2,6 M € | +0.2% | -2,6 M € | +1.3% | -2,6 M € | +5.6% | -2,8 M € | -28.7% | -2,2 M € | -11.2% | -1,9 M € | -53.9% | -1,3 M € | -101.3% | -628,8 k € | |
| Equity | -3,6 M € | -7.2% | -3,3 M € | -78.5% | -1,9 M € | -328.3% | 816,3 k € | -57.3% | 1,9 M € | -4.9% | 2,0 M € | -56.7% | 4,6 M € | +247.0% | 1,3 M € | -61.8% | 3,5 M € | +42.9% | 2,5 M € | -17.4% | 3,0 M € | |
| Total assets | 168,5 k € | -39.1% | 276,5 k € | -84.6% | 1,8 M € | -23.5% | 2,3 M € | -6.2% | 2,5 M € | +3.4% | 2,4 M € | -52.0% | 5,0 M € | +183.6% | 1,8 M € | -57.4% | 4,2 M € | +51.1% | 2,8 M € | -19.9% | 3,4 M € | |
| Cash | 7,1 k € | -89.4% | 67,3 k € | -93.5% | 1,0 M € | -33.2% | 1,6 M € | +18.3% | 1,3 M € | -5.3% | 1,4 M € | -64.5% | 3,9 M € | +879.9% | 400,1 k € | -85.7% | 2,8 M € | +65.2% | 1,7 M € | -23.3% | 2,2 M € | |
| Debts | 3,0 M € | -1.4% | 3,0 M € | -11.4% | 3,4 M € | +124.6% | 1,5 M € | +159.9% | 588,9 k € | +44.4% | 407,8 k € | +16.4% | 350,4 k € | -7.4% | 378,3 k € | -19.7% | 471,1 k € | +118.7% | 215,4 k € | -52.2% | 450,9 k € | |
| Staff | — | 3,8 | 10,8 | 11,3 | 13,8 | 13,3 | 12,7 | 12,4 | 10,6 | 7,9 | 4,3 | |||||||||||
Public limited company loss-making in the latest fiscal year. Cash position declining (-89.4%).
Solid counterparty for a standard engagement.
ViroVet is a Public limited company incorporated in 2015. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette